Accelerated Disease Progression after Discontinuation of Sorafenib in a Patient with Metastatic Papillary Thyroid Cancer
Kyung-Jin Yun (Yun KJ), Woohyeon Kim (Kim W), Eun Hee Kim (Kim EH), Min-Hee Kim (Kim MH), Dong-Jun Lim (Lim DJ), Moo-Il Kang (Kang MI), Bong-Yun Cha (Cha BY)
Endocrinol Metab. 2014;29(3):388-393.   Published online 2014 Sep 25     DOI: https://doi.org/10.3803/EnM.2014.29.3.388
Citations to this article as recorded by Crossref logo
Rapid disease progression after discontinuation of lenvatinib in thyroid cancer
Haruhiko Yamazaki, Kiminori Sugino, Kenichi Matsuzu, Chie Masaki, Junko Akaishi, Kiyomi Hames, Chisato Tomoda, Akifumi Suzuki, Takashi Uruno, Keiko Ohkuwa, Wataru Kitagawa, Mitsuji Nagahama, Munetaka Masuda, Koichi Ito
Medicine.2020; 99(11): e19408.     CrossRef
Lenvatinib for thyroid cancer treatment: discovery, pre-clinical development and clinical application
Rosa Maria Paragliola, Andrea Corsello, Valeria Del Gatto, Giampaolo Papi, Alfredo Pontecorvi, Salvatore Maria Corsello
Expert Opinion on Drug Discovery.2020; 15(1): 11.     CrossRef
Efficacy and Limitations of Lenvatinib Therapy for Radioiodine-Refractory Differentiated Thyroid Cancer: Real-World Experiences
Chie Masaki, Kiminori Sugino, Naoko Saito, Junko Akaishi, Kiyomi Y. Hames, Chisato Tomoda, Akifumi Suzuki, Kenichi Matsuzu, Takashi Uruno, Keiko Ohkuwa, Wataru Kitagawa, Mitsuji Nagahama, Koichi Ito
Thyroid.2020; 30(2): 214.     CrossRef
Papillary thyroid carcinoma with hyperthyroidism and multiple metastases
Li-li Zhang, Bin Liu, Fang-fang Sun, Hong-yu Li, Shuang Li, Li-rong Zhao
Medicine.2020; 99(30): e21346.     CrossRef
Missing Skeletal Muscle Metastases of Papillary Thyroid Carcinoma
Leszek Herbowski
Diagnostics.2020; 10(7): 457.     CrossRef
Reply to “Missing Skeletal Muscle Metastases of Papillary Thyroid Carcinoma”
Liviu Hitu, Calin Cainap, Dragos Apostu, Katalin Gabora, Eduard-Alexandru Bonci, Marius Badan, Alexandru Mester, Andra Piciu
Diagnostics.2020; 10(7): 458.     CrossRef
Hif-1α Inhibitors Could Successfully Inhibit the Progression of Differentiated Thyroid Cancer in Vitro
Min-Hee Kim, Tae Hyeong Lee, Jin Soo Lee, Dong-Jun Lim, Peter Chang-Whan Lee
Pharmaceuticals.2020; 13(9): 208.     CrossRef
Extended Real-World Observation of Patients Treated with Sorafenib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Impact of Lenvatinib Salvage Treatment: A Korean Multicenter Study
Hye-Seon Oh, Dong Yeob Shin, Mijin Kim, So Young Park, Tae Hyuk Kim, Bo Hyun Kim, Eui Young Kim, Won Bae Kim, Jae Hoon Chung, Young Kee Shong, Dong Jun Lim, Won Gu Kim
Thyroid.2019; 29(12): 1804.     CrossRef
Rapid pleural effusion after discontinuation of lenvatinib in a patient with pleural metastasis from thyroid cancer
Taisuke Uchida, Hideki Yamaguchi, Kazuhiro Nagamine, Tadato Yonekawa, Eriko Nakamura, Nobuhiro Shibata, Fumiaki Kawano, Yujiro Asada, Masamitsu Nakazato
Endocrinology, Diabetes & Metabolism Case Reports.2019;[Epub]     CrossRef
Thyroid Disorders in the Elderly
Kevin Higgins
Clinics in Geriatric Medicine.2018; 34(2): 259.     CrossRef
Treatment of refractory thyroid cancer
Amandine Berdelou, Livia Lamartina, Michele Klain, Sophie Leboulleux, Martin Schlumberger, _ _
Endocrine-Related Cancer.2018; 25(4): R209.     CrossRef
Clinical guidance for radioiodine refractory differentiated thyroid cancer
Matti L. Gild, Duncan J. Topliss, Diana Learoyd, Francis Parnis, Jeanne Tie, Brett Hughes, John P. Walsh, Donald S.A. McLeod, Roderick J. Clifton-Bligh, Bruce G. Robinson
Clinical Endocrinology.2018; 88(4): 529.     CrossRef
Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible Patients
Thomas J. Smith, Nasser Hanna, David Johnson, Sherman Baker, William A. Biermann, Julie Brahmer, Peter M. Ellis, Giuseppe Giaccone, Paul J. Hesketh, Ishmael Jaiyesimi, Natasha B. Leighl, Gregory J. Riely, Joan H. Schiller, Bryan J. Schneider, Joan Tashbar
Journal of Oncology Practice.2017; 13(12): 780.     CrossRef
Intermittent Dosing of Dabrafenib and Trametinib in Metastatic BRAFV600E Mutated Papillary Thyroid Cancer: Two Case Reports
Paul S. White, Anita Pudusseri, Stephanie L. Lee, Omar Eton
Thyroid.2017; 27(9): 1201.     CrossRef
Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report
Fabiana Pani, Elisabetta Macerola, Fulvio Basolo, Francesco Boi, Mario Scartozzi, Stefano Mariotti
Oncology Letters.2017; 14(2): 2186.     CrossRef
Tumors Sharply Increased after Ceasing Pazopanib Therapy for a Patient with Advanced Uterine Leiomyosarcoma: Experience of Tumor Flare
Terumi Tanigawa, Shintaro Morisaki, Hisanobu Fukuda, Shuichiro Yoshimura, Hisayoshi Nakajima, Kohei Kotera
Case Reports in Obstetrics and Gynecology.2017; 2017: 1.     CrossRef
Initial Size of Metastatic Lesions Is Best Prognostic Factor in Patients with Metastatic Differentiated Thyroid Carcinoma Confined to the Lung
Mijin Kim, Won Gu Kim, Suyeon Park, Hyemi Kwon, Min Ji Jeon, Jong Jin Lee, Jin-Sook Ryu, Tae Yong Kim, Young Kee Shong, Won Bae Kim
Thyroid.2017; 27(1): 49.     CrossRef
Articles in 'Endocrinology and Metabolism' in 2014
Won-Young Lee
Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
Pharmacodynamic study of axitinib in patients with advanced malignancies assessed with 18F-3′deoxy-3′fluoro-l-thymidine positron emission tomography/computed tomography
Justine Yang Bruce, Peter Colin Scully, Lakeesha L. Carmichael, Jens C. Eickhoff, Scott B. Perlman, Jill Marie Kolesar, Jennifer L. Heideman, Robert Jeraj, Glenn Liu
Cancer Chemotherapy and Pharmacology.2015; 76(1): 187.     CrossRef
Optimal Differentiated Thyroid Cancer Management in the Elderly
Donald S. A. McLeod, Kelly Carruthers, Dev A. S. Kevat
Drugs & Aging.2015; 32(4): 283.     CrossRef